Search
01/06/2022
Socioeconomic inequalities and COVID-19 in Spain. SESPAS Report 2022
Bacigalupe, A, Martin, U, Franco, M, Borrell, C. Socioeconomic inequalities and COVID-19 in Spain. SESPAS Report 2022. Gaceta Sanitaria. 2022; 36DOI:10.1016/j.gaceta.2022.01.011. PMID:35781142. IF:1.900(Q3/8D).
01/06/2022
Lyophilized amniotic membrane graft for primary pterygium surgery: preliminary results
Sabater-Cruz, N, Martinez-Conesa, E, Vilarrodona, A, Casaroli-Marano, RP. Lyophilized amniotic membrane graft for primary pterygium surgery: preliminary results. CELL AND TISSUE BANKING. 2022; 23(2)DOI:10.1007/s10561-021-09955-3. PMID:34628551. IF:1.500(Q4/9D).
01/06/2022
Prognosis of acute heart failure based on clinical data of congestion
Espinosa B., Llorens P., Gil V., Rossello X., Jacob J., Herrero P., Martín-Sánchez F.J., Alquézar-Arbé A., Masip J., Miró Ò.. Prognosis of acute heart failure based on clinical data of congestion. REVISTA CLINICA ESPANOLA. 2022; 222(6)DOI:10.1016/j.rce.2021.07.003. PMID:34756646. IF:2.900(Q2/5D).
01/06/2022
Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials
Chabra, S, Gill, BJ, Gallo, G, Zhu, DT, Pitou, C, Payne, CD, Accioly, A, Puig, L. Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials. ADVANCES IN THERAPY. 2022; 39(6)DOI:10.1007/s12325-022-02126-0. PMID:35449322. IF:3.800(Q2/4D).
01/06/2022
A cohort study of guselkumab in the treatment of psoriasis refractory to previous biologic therapies: effectiveness, safety and adherence
Medina-Catalan, D, Riera, P, Pages-Puigdemont, N, Masip, M, Lopez-Ferrer, A, Vilarrasa, E, Puig, L. A cohort study of guselkumab in the treatment of psoriasis refractory to previous biologic therapies: effectiveness, safety and adherence. International Journal of Clinical Pharmacy. 2022; 44(3)DOI:10.1007/s11096-022-01400-z. PMID:35380392. IF:2.400(Q3/8D).
01/06/2022
Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
de Bruin-Weller, MS, Serra-Baldrich, E, Barbarot, S, Grond, S, Schuster, C, Petto, H, Capron, JP, Raibouaa, A, Werfel, T. Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis. Dermatology and Therapy. 2022; 12(6)DOI:10.1007/s13555-022-00734-w. PMID:35543919. IF:3.400(Q2/3D).